Dukart Juergen, Smieskova Renata, Harrisberger Fabienne, Lenz Claudia, Schmidt André, Walter Anna, Huber Christian, Riecher-Rössler Anita, Simon Andor, Lang Undine E, Fusar-Poli Paolo, Borgwardt Stefan
From the F. Hoffmann-La Roche, Pharma Research Early Development, Roche Innovation Centre Basel, Basel, Switzerland (Dukart); the Department of Psychiatry (UPK), University of Basel, Basel, Switzerland (Dukart, Smieskova, Lenz, Schmidt, Walter, Huber, Riecher-Rössler, Lang, Borgwardt); the University Hospital of Psychiatry, University Hospital of Bern, Bern, Switzerland, and Specialized Early Psychosis Outpatient Service for Adolescents and Young Adults, Department of Psychiatry, Bruderholz, Switzerland (Simon); and the Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience IoPPN), King's College London, London, UK (Schmidt, Borgwardt).
J Psychiatry Neurosci. 2017 Sep;42(5):307-319. doi: 10.1503/jpn.160179.
There is only limited agreement with respect to location, directionality and functional implications of brain structural alterations observed in patients with schizophrenia. Additionally, their link to occurrence of psychotic symptoms remains unclear. A viable way of addressing these questions is to examine populations in an at-risk mental state (ARMS) before the transition to psychosis.
We tested for structural brain alterations in individuals in an ARMS compared with healthy controls and patients with first-episode psychosis (FEP) using voxel-based morphometry and measures of cortical thickness. Furthermore, we evaluated if these alterations were modified by age and whether they were linked to the observed clinical symptoms.
Our sample included 59 individuals with ARMS, 26 healthy controls and 59 patients with FEP. We found increased grey matter volume and cortical thickness in individuals with ARMS and a similar pattern of structural alterations in patients with FEP. We further found stronger age-related reductions in grey matter volume and cortical thickness in both patients with FEP and individuals with ARMS, linking these alterations to observed clinical symptoms.
The ARMS group comprised subgroups with heterogeneous levels of psychosis risk and medication status. Furthermore, the cross-sectional nature of our study and the reduced number of older patients limit conclusions with respect to observed interactions with age.
Our findings on consistent structural alterations in individuals with ARMS and patients with FEP and their link to clinical symptoms have major implications for understanding their time of occurrence and relevance to psychotic symptoms. Interactions with age found for these alterations may explain the heterogeneity of findings reported in the literature.
对于精神分裂症患者脑部结构改变的位置、方向性及功能影响,仅存在有限的共识。此外,这些改变与精神病性症状发生之间的联系仍不明确。解决这些问题的一个可行方法是在向精神病转变之前检查处于高危精神状态(ARMS)的人群。
我们使用基于体素的形态测量法和皮质厚度测量法,对处于ARMS的个体与健康对照者及首发精神病(FEP)患者的脑部结构改变进行了检测。此外,我们评估了这些改变是否因年龄而有所不同,以及它们是否与观察到的临床症状相关。
我们的样本包括59名处于ARMS的个体、26名健康对照者和59名FEP患者。我们发现处于ARMS的个体灰质体积和皮质厚度增加,FEP患者也有类似的结构改变模式。我们还进一步发现,FEP患者和处于ARMS的个体的灰质体积和皮质厚度随年龄增长的减少更为明显,将这些改变与观察到的临床症状联系起来。
ARMS组包括精神病风险和用药状态水平各异的亚组。此外,我们研究的横断面性质以及老年患者数量的减少限制了关于观察到的与年龄相互作用的结论。
我们关于处于ARMS的个体和FEP患者一致的结构改变及其与临床症状的联系的发现,对于理解这些改变的发生时间及其与精神病性症状的相关性具有重要意义。这些改变与年龄的相互作用可能解释了文献中报道的研究结果的异质性。